XTANT MEDICAL HOLDINGS, INC. Repayments of Long-Term Debt
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Repayments of Long-Term Debt of $3.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for the quarter ending 2026-06-30 was $930.00K.
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for the quarter ending 2026-03-31 was $2.84M.
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for the quarter ending 2025-12-31 was $3.00M.
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for fiscal 2025 was $8.00M.
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for fiscal 2021 was $411.00K, a 30.48% increase from fiscal 2020.
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for fiscal 2020 was $315.00K.
- XTANT MEDICAL HOLDINGS, INC. repayments of long-term debt for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $930.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.77M 10-Q · filed 2026-08-11 | $6.77M derived: sum of 3 quarters · filed 2026-08-11 | |
| 2026-03-31 | $2.84M 10-Q · filed 2026-05-13 | $5.84M derived: sum of 2 quarters · filed 2026-05-13 | ||
| 2025-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $8.00M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $5.00M 10-Q · filed 2025-11-10 | |||
| 2024-09-30 | $648.00K 10-Q · filed 2024-11-12 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$73.00K derived: sum of 2 quarters · filed 2023-03-07 | $103.00K derived: sum of 3 quarters · filed 2023-03-07 | $411.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | -$73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $103.00K derived: sum of 2 quarters · filed 2022-11-03 | $411.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $484.00K 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $308.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $315.00K 10-K · filed 2022-03-08 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 10-K · filed 2017-03-29 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | |||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-11 | $1.29M derived: sum of 2 quarters · filed 2017-03-29 | $1.30M derived: sum of 3 quarters · filed 2017-03-29 | $1.15M derived: sum of 4 quarters · filed 2017-03-29 |
| 2015-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $1.30M derived: sum of 2 quarters · filed 2017-03-29 | $1.15M derived: sum of 3 quarters · filed 2017-03-29 | $1.33M 10-K · filed 2017-03-29 |
| 2015-09-30 | $12.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$133.02K derived: sum of 2 quarters · filed 2016-11-10 | $38.67K 10-Q · filed 2016-11-10 | $199.37K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | -$145.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $25.73K 10-Q · filed 2016-08-10 | $186.43K derived: sum of 3 quarters · filed 2016-08-10 | $654.88K derived: sum of 4 quarters · filed 2016-08-10 |
| 2015-03-31 | $171.69K 10-Q · filed 2016-05-11 | $332.39K derived: sum of 2 quarters · filed 2016-05-11 | $800.84K derived: sum of 3 quarters · filed 2016-05-11 | $795.89K derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $160.70K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | $629.15K derived: sum of 2 quarters · filed 2016-03-24 | $624.20K derived: sum of 3 quarters · filed 2016-03-24 | $653.40K 10-K · filed 2016-03-24 |
| 2014-09-30 | $468.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $463.50K derived: sum of 2 quarters · filed 2015-11-16 | $492.69K 10-Q · filed 2015-11-16 | $1.08M derived: sum of 4 quarters · filed 2015-11-16 |
| 2014-06-30 | -$4.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $24.24K 10-Q · filed 2015-08-14 | $611.90K derived: sum of 3 quarters · filed 2015-08-14 | $623.36K derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | $29.19K 10-Q · filed 2015-05-06 | $616.85K derived: sum of 2 quarters · filed 2015-05-06 | $628.31K derived: sum of 3 quarters · filed 2015-05-06 | $639.13K derived: sum of 4 quarters · filed 2015-05-06 |
| 2013-12-31 | $587.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $599.12K derived: sum of 2 quarters · filed 2015-03-18 | $609.93K derived: sum of 3 quarters · filed 2015-03-18 | $621.97K 10-K · filed 2015-03-18 |
| 2013-09-30 | $11.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $22.28K derived: sum of 2 quarters · filed 2014-11-07 | $34.31K 10-Q · filed 2014-11-07 | $45.72K derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | $10.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $22.85K 10-Q · filed 2014-08-14 | $34.26K derived: sum of 3 quarters · filed 2014-08-14 | $9.36M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $12.03K 10-Q · filed 2014-05-12 | $23.44K derived: sum of 2 quarters · filed 2014-05-12 | $9.35M derived: sum of 3 quarters · filed 2014-05-12 | $9.79M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $11.41K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $9.34M derived: sum of 2 quarters · filed 2014-03-27 | $9.77M derived: sum of 3 quarters · filed 2014-03-27 | $9.78M 10-K · filed 2014-03-27 |
| 2012-09-30 | $9.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $9.76M derived: sum of 2 quarters · filed 2013-11-14 | $9.77M 10-Q · filed 2013-11-14 | $9.78M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $434.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | $445.53K 10-Q · filed 2013-08-13 | $456.06K derived: sum of 3 quarters · filed 2013-08-13 | $5.47M derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $10.68K 10-Q · filed 2013-05-10 | $21.21K derived: sum of 2 quarters · filed 2013-05-10 | $5.04M derived: sum of 3 quarters · filed 2013-05-10 | $5.12M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $10.53K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $5.03M derived: sum of 2 quarters · filed 2013-03-27 | $5.11M derived: sum of 3 quarters · filed 2013-03-27 | $5.12M 10-K · filed 2013-03-27 |
| 2011-09-30 | $5.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $5.10M derived: sum of 2 quarters · filed 2012-11-08 | $5.10M 10-Q · filed 2012-11-08 | $6.47M derived: sum of 4 quarters · filed 2012-11-08 |
| 2011-06-30 | $82.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $86.16K 10-Q · filed 2012-08-10 | $1.45M derived: sum of 3 quarters · filed 2012-08-10 | $1.47M derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | $3.74K 10-Q · filed 2012-05-04 | $1.37M derived: sum of 2 quarters · filed 2012-05-04 | $1.39M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $1.38M derived: sum of 2 quarters · filed 2012-03-29 | $1.59M 10-K · filed 2012-03-29 | |
| 2010-09-30 | $20.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $224.79K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $204.27K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |